BI-SPECIFIC T CELL ENGAGERS TARGETING IL13RA2 ACTIVATE TUMOR-INFILTRATING LYMPHOCYTES AND IMPROVE SURVIVAL IN PRE-CLINICAL MODELS OF GLIOBLASTOMA

被引：0
|
作者：
Zannikou, M. [1 ]
Pituch, K. C. [1 ]
Ilut, L. [1 ]
Balyasnikova, I. V. [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
10.1093/neuonc/noz126.214
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P12.03
引用
收藏
页码：59 / 60
页数：2
相关论文
共 8 条
  • [1] Bispecific T Cell Engager (BiTE) Targeting IL13Rα2 Improves Survival in a Pre-Clinical Model of Glioblastoma. Bispecific T Cell Engager (BiTE) Targeting IL13Rα2 Improves Survival in a Pre-Clinical Model of Glioblastoma
    Zannikou, Markella
    Pituch, Katarzyna C.
    Ilut, Liliana
    Balyasnikova, Irina V.
    MOLECULAR THERAPY, 2019, 27 (04) : 267 - 267
  • [2] NEXT-GENERATION CAR T-CELLS TARGETING IL13RA2 AND SECRETING IL-15 ACHIEVE DURABLE TUMOUR CLEARANCE IN PRE-CLINICAL MODEL OF DIFFUSE MIDLINE GLIOMA
    Hotblack, Alastair
    Wawrzyniecka, Patrycja
    Cheng, Gordon Weng-Kit
    Nannini, Francesco
    Pule, Martin
    Straathof, Karin
    NEURO-ONCOLOGY, 2022, 24 : 85 - 85
  • [3] GLIOMA IL13RA2 EXPRESSION CORRELATES WITH IL13-ZETAKINE+ T CELL KILLING OF CANCER STEM-LIKE CELLS AND IS ASSOCIATED WITH CLINICAL TUMOR REGRESSION FOLLOWING ADOPTIVE T CELL THERAPY
    Brown, Christine E.
    Starr, Renate
    Martinez, Catalina
    Bading, James
    Ressler, Julie Ann
    Badie, Behnam
    Jensen, Michael C.
    NEURO-ONCOLOGY, 2010, 12 : 35 - 35
  • [4] IL-15 is Superior to IL-2 in Supporting Antigen-specific Expansion and Maintenance of T-cell Memory in Melanoma CD8+ Tumor-infiltrating Lymphocytes
    Li, Yufeng
    Hernandez, Jessica
    Wu, Richard
    Hwu, Patrick
    Radvanyi, Laszlo
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (09) : 948 - 948
  • [5] Phosphatidylserine targeting antibody in combination with anti-PD-1 antibody treatment activates infiltrating T lymphocytes of the spleen and tumor microenvironment in pre-clinical models of melanoma and breast cancer.
    Huang, Xianming
    Gong, Jian
    Van Nguyen
    Yin, Shen
    Baldwin, Carrie
    Brekken, Rolf A.
    King, Steven
    Hutchins, Jeff
    Freimark, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] In vivo DNA-launched bispecific T cell engager targeting IL-13Ra2 controls tumor growth in an animal model of glioblastoma multiforme
    Bhojnagarwala, Pratik S.
    O'Connell, Ryan P.
    Park, Daniel
    Liaw, Kevin
    Ali, Ali R.
    Bordoloi, Devivasha
    Cassel, Joel
    Tursi, Nicholas J.
    Gary, Ebony
    Weiner, David B.
    MOLECULAR THERAPY ONCOLYTICS, 2022, 26 : 289 - 301
  • [7] A single administration of DNA-encoded trispecific T cell engager (DTriTE) targeting EGFRvIII, IL13Ra2, and CD3 shows complete tumor clearance in an orthotopic challenge model of heterogeneous GBM
    Park, Daniel Hongil
    Bhojnagarwala, Pratik
    Liaw, Kevin
    Bordoloi, Devivasha
    Gary, Ebony N.
    Weiner, David B.
    CANCER RESEARCH, 2023, 83 (07)
  • [8] Clinical and histopathological aspects of 113 necrotizing malignant melanomas of the choroid. 2. Immunogenetic characterization of T-cell receptor-positive tumor-infiltrating lymphocytes and survival of patients with necrotizing melanomas of the choroid
    Bialasiewicz, AA
    Ma, JX
    Richard, G
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1998, 213 (05) : 271 - 277
1